FOLFOX for Stage II Colon Cancer? A Commentary on the Recent FDA Approval of Oxaliplatin for Adjuvant Therapy of Stage III Colon Cancer
Journal of Clinical Oncology
Vol 23, No 15 (May 20), 2005: pp. 3311-3313
Axel Grothey and Daniel J. Sargent
DOI: 10.1200/JCO.2005.11.691
Go to free full text of commentary.
Commentary: FDA Approval of Oxaliplatin for Stage 3 Colon CancerCancer Research May 2005
From Donna Myers, former About.com Guide
Updated: August 5, 2005
About.com Health's Disease and Condition content is reviewed by the Medical Review Board
Explore Colon Cancer
Must Reads
About.com Special Features
8 Ways to Cut Drug Costs
Learn how to save money on medications with these recommendations. More >
Healthy Bodies, Healthy Minds
Keep yourself, and your family, happy and healthy this fall with these tips. More >
Also from About.com:
©2009 About.com, a part of The New York Times Company.
All rights reserved.